1 code implementation • 7 Oct 2021 • Qing Lyu, Sanjeev V. Namjoshi, Emory McTyre, Umit Topaloglu, Richard Barcus, Michael D. Chan, Christina K. Cramer, Waldemar Debinski, Metin N. Gurcan, Glenn J. Lesser, Hui-Kuan Lin, Reginald F. Munden, Boris C. Pasche, Kiran Kumar Solingapuram Sai, Roy E. Strowd, Stephen B. Tatter, Kounosuke Watabe, Wei zhang, Ge Wang, Christopher T. Whitlow
Treatment decisions for brain metastatic disease rely on knowledge of the primary organ site, and currently made with biopsy and histology.
no code implementations • 16 Feb 2019 • Meiyu Li, Hailiang Tang, Michael D. Chan, Xiaobo Zhou, Xiaohua Qian
Pseudoprogression (PsP) occurs in 20-30% of patients with glioblastoma multiforme (GBM) after receiving the standard treatment.